DP3
Dược phẩm Trung ương 3 ·HNX ·2026Q1
▲▲ Improving positively
TTM · Applied to: EPS, ROE, ROA, Net Margin, Asset Turnover, Debt/Equity
What Is Changing
On a TTM 2026Q1 basis, DP3 has not accelerated revenue sharply, but profitability is improving visibly — profit is at an all-time high. Profit growth is driven mainly by better operations rather than scale expansion — a foundation that tends to be more durable.
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 135.0 | 131.6 | 120.2 | 94.2 | 91.9 | 116.2 | 95.2 | 102.4 | 103.7 | 98.0 | 91.1 | 100.9 |
| Growth | +3% | +9% | +28% | +3% | -21% | +22% | -7% | -1% | +6% | +8% | -10% | — |
| Net Income | 34.8 | 74.6 | 23.0 | 32.1 | 23.9 | 50.1 | 21.3 | 27.7 | 22.0 | 50.5 | 18.9 | 31.6 |
| Net Margin | 25.76% | 56.65% | 19.15% | 34.06% | 25.97% | 43.12% | 22.37% | 27.08% | 21.26% | 51.57% | 20.71% | 31.33% |
Drivers of DP3's profit
Net profit attributable to parent increased vs last year, mainly helped by higher gross profit. Supporting and offsetting drivers:
Net profit attributable to parent increased vs prior quarter, mainly helped by higher gross profit. Supporting and offsetting drivers:
Financial Highlights
Detailed analysis of each financial dimension
ROE = Profit Margin × Asset Turnover × Equity Multiplier
ROE rose from 23.8% to 27.7% — mainly driven by leverage, despite asset turnover moving in the opposite direction.
Is the profit sustainable?
Margins are improving and earnings quality is solid — a durable foundation for ROE.
What is driving the margin?
Net margin expanded to 34.19%, rising 3.9pp. The main driver is SG&A / Revenue fell 2.6pp and Gross margin rose 1.3pp, moving in line with the stronger net margin (with additional support from Net financial result / Revenue rose 0.9pp).
The improvement comes from core operations — this is a high-quality margin expansion.
Profitability trend
TTM YoY · 2025Q1 -> 2026Q1
Is capital being used efficiently?
Return on capital rose, but cash cycle lengthened by 4.8 days — working capital needs watching.
Is capital being deployed efficiently?
ROIC expanded to 26.65%, rising 3.0pp. That translates to 26.65 in after-tax operating profit for every 100 units of operating capital. The main driver is NOPAT margin rose 3.8pp, with capital turnover broadly stable; while invested capital rose by 96bn.
Capital efficiency improved through NOPAT margin — this is a quality-led improvement when operating profit leads.
CAPITAL EFFICIENCY TREND
TTM YoY · 2025Q1 -> 2026Q1
Balance Sheet
ROIC is improving — the asset structure below shows how capital is being allocated. Capital structure is conservative with low leverage — liabilities at 0.24x equity, net debt at 0.05x equity.
Over the last 12 months, working capital released 0.0bn of cash.
Working Capital Drivers
TTM YoY · 2025Q1 -> 2026Q1
Working Capital Efficiency
Cash conversion cycle lengthened by 4.8 days versus the same period last year. The main moves came from DIO fell 3.2 days, DSO rose 2.2 days, and DPO fell 5.8 days.
Working capital cycle lengthened mainly due to shorter payment timing — may reflect pressure from suppliers.
Watchpoints
CCC stands at 133.3 days, suggesting that working capital remains tied up for a relatively long operating cycle.
DSO increased by +2.2 days, pointing to slower receivables turnover.
Working Capital Efficiency
TTM YoY · 2025Q1 -> 2026Q1
Is financial risk significant?
Check leverage, liquidity, and cash-flow conversion.
Leverage & Liquidity
Leverage looks fairly comfortable, with net debt / equity at 0.05x and interest coverage at 161.37x.
At present, short-term debt accounts for 100.0% of total debt, cash equals 11.3% of debt, and total debt stands at 32.8bn.
Watchpoints
Short-term debt accounts for 100.0% of total debt, raising near-term refinancing needs.
Cash / debt stands at 11.3%, leaving limited liquidity buffer to monitor.
Leverage and liquidity trend
TTM YoY · 2025Q1 -> 2026Q1
Cash Flow
With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 151.5bn in 2025, against investing cash flow of -130.6bn.
Post-investment cash flow was positive +20.9bn. Financing cash flow was negative +30.2bn.
CFO / net income was 1.11x.
Track how much investment can be funded internally from operating cash flow.
Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.
Cash Conversion
TTM Cash Conversion · 2025Q1 -> 2026Q1
Investment Takeaway
The business is entering a broader improvement phase — not just stronger earnings but better operating quality as well. Margin, ROIC, and cash flow all improving shows the business is growing in a cleaner and more efficient way than before. Notably, the improvement trend has been confirmed across multiple cycles, from margin to capital efficiency and cash generation. Even so, cash generation still needs confirmation remains the area to verify in upcoming periods. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 133 days.
Improvement: operating efficiency is getting better, with trailing-12M net margin at 34.19% after expanding 3.9pp versus the same period last year.
Watchpoint: Cash generation still needs confirmation.
Key risk: working capital remains tied up for too long, with cash cycle at 133.3 days.
Statement Data
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
|
Net Revenue
|
437.9 | 417.5 | 409.7 | 485.1 | 381.1 |
|
Cost of Goods Sold
|
150.3 | 141.4 | 128.2 | 148.5 | 0.0 |
|
Gross Profit
|
287.6 | 276.1 | 281.5 | 336.5 | 263.6 |
|
Financial Expenses
|
0.8 | 0.3 | 1.9 | 2.2 | -1.4 |
|
Selling Expenses
|
77.9 | 94.1 | 74.2 | 135.1 | -95.5 |
|
General and Administrative Expenses
|
39.4 | 45.3 | 70.4 | 73.7 | -56.0 |
|
Operating Profit
|
192.3 | 151.8 | 156.6 | 136.4 | 118.1 |
|
Profit Before Tax
|
192.6 | 151.9 | 157.0 | 136.5 | 118.2 |
|
Net Income
|
156.1 | 121.2 | 125.3 | 108.8 | 94.3 |
|
Profit Attributable to Parent
|
156.1 | 121.2 | 125.3 | 108.8 | 94.3 |
|
Earnings per Share
|
7,259.00 | 5,636.00 | 5,826.00 | 12,021.00 | 10,965.00 |
Explore Other Stocks In The Same Sector
DHG, DVN, IMP, DBD, DTP, TRA, DMC, OPC, NDC, DAN, PMC, VDP, DHT, FIT, DHD, AGP, DVM, CNC, PBC, LDP, DPH, VMD, NDP, HDP, DCL, PPP, VET, MTP, MKV, DHN, MED, DBT, DTG, DPP, BIO, VNY, DBM, MKP, TW3, DTH, NTF, BCP, UPH, SPM, DP2, VXP
Need support? If you need support with content lookup or want to provide feedback about content on the website, please contact us below.